PT2820010T - Monitorização de minerais preciosos - Google Patents

Monitorização de minerais preciosos

Info

Publication number
PT2820010T
PT2820010T PT13711995T PT13711995T PT2820010T PT 2820010 T PT2820010 T PT 2820010T PT 13711995 T PT13711995 T PT 13711995T PT 13711995 T PT13711995 T PT 13711995T PT 2820010 T PT2820010 T PT 2820010T
Authority
PT
Portugal
Prior art keywords
benzofuran
chemokine receptor
receptor modulators
sulfonamide derivatives
sulfonamide
Prior art date
Application number
PT13711995T
Other languages
English (en)
Inventor
L Beard Richard
E Donello John
E Garst Michael
Viswanath Veena
Yuan Haiqing
Liu Xiaoxia
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of PT2820010T publication Critical patent/PT2820010T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT13711995T 2012-03-01 2013-03-01 Monitorização de minerais preciosos PT2820010T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261605300P 2012-03-01 2012-03-01

Publications (1)

Publication Number Publication Date
PT2820010T true PT2820010T (pt) 2018-10-01

Family

ID=47902352

Family Applications (2)

Application Number Title Priority Date Filing Date
PT13711995T PT2820010T (pt) 2012-03-01 2013-03-01 Monitorização de minerais preciosos
PT181560111T PT3345899T (pt) 2012-03-01 2013-03-01 Derivados de benzofurano-2-sulfonamida como moduladores dos receptores de quimioquinas

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT181560111T PT3345899T (pt) 2012-03-01 2013-03-01 Derivados de benzofurano-2-sulfonamida como moduladores dos receptores de quimioquinas

Country Status (12)

Country Link
US (4) US8815915B2 (pt)
EP (2) EP2820010B1 (pt)
AU (2) AU2013225815B2 (pt)
CA (1) CA2866078C (pt)
CY (1) CY1120528T1 (pt)
DK (2) DK2820010T3 (pt)
ES (2) ES2791534T3 (pt)
HU (2) HUE038700T2 (pt)
PL (2) PL3345899T3 (pt)
PT (2) PT2820010T (pt)
SI (1) SI2820010T1 (pt)
WO (2) WO2013130962A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2820010B1 (en) * 2012-03-01 2018-05-09 Allergan, Inc. Benzofuran-2-sulfonamide derivatives as chemokine receptor modulators
WO2014159657A1 (en) * 2013-03-12 2014-10-02 Allergan, Inc. Pyridinyl and pyrimidinyl sulfonamide derivatives as chemokine receptor modulators
WO2015084869A1 (en) * 2013-12-02 2015-06-11 Allergan, Inc. Benzothiophene sulfonamides derivatives as chemokine receptor modulators

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003248549B2 (en) 2002-05-24 2010-04-08 Millennium Pharmaceuticals, Inc. CCR9 inhibitors and methods of use thereof
US20070021466A1 (en) * 2002-11-18 2007-01-25 Solomon Ungashe CCR2 inhibitors and methods of use thereof
US7420055B2 (en) 2002-11-18 2008-09-02 Chemocentryx, Inc. Aryl sulfonamides
US7393873B2 (en) 2003-07-02 2008-07-01 Merck & Co., Inc. Arylsulfonamide derivatives
NZ545030A (en) * 2003-08-08 2009-08-28 Janssen Pharmaceutica Nv 2-(Quinoxalin-5-ylsulfonylamino) -benzamide compounds as CCK2 modulators
US7622583B2 (en) * 2005-01-14 2009-11-24 Chemocentryx, Inc. Heteroaryl sulfonamides and CCR2
US7931909B2 (en) 2005-05-10 2011-04-26 Allergan, Inc. Ocular therapy using alpha-2 adrenergic receptor compounds having enhanced anterior clearance rates
GB0524786D0 (en) 2005-12-05 2006-01-11 Glaxo Group Ltd Compounds
US20100234364A1 (en) 2006-07-14 2010-09-16 Arindrajit Basak Ccr2 inhibitors and methods of use thereof
MX2009000395A (es) * 2006-07-14 2009-01-29 Chemocentryx Inc Triazolil fenil bencenosulfonamidas.
US8519135B2 (en) 2006-07-14 2013-08-27 Chemocentryx, Inc. Heteroaryl sulfonamides and CCR2/CCR9
CA2692761C (en) 2007-07-12 2013-04-30 Chemocentryx, Inc. Fused heteroaryl pyridyl and phenyl benzenesulfonamides as ccr2 modulators for the treament of inflammation
TWI440638B (zh) * 2007-10-30 2014-06-11 Otsuka Pharma Co Ltd 雜環化合物及其藥學組成物
EP2651957B1 (en) * 2010-12-16 2015-02-18 Allergan, Inc. Phosphorous derivatives as chemokine receptor modulators
EP2955173B1 (en) * 2010-12-16 2017-10-04 Allergan, Inc. 1,2-bis-sulfonamide derivatives as chemokine receptor modulators
CA2859024C (en) * 2011-12-12 2016-11-08 Allergan, Inc. Benzisothiazol-3(1h)-one-5-sulfonyl derivatives as chemokine receptor modulators
EP2820010B1 (en) * 2012-03-01 2018-05-09 Allergan, Inc. Benzofuran-2-sulfonamide derivatives as chemokine receptor modulators
WO2014159657A1 (en) * 2013-03-12 2014-10-02 Allergan, Inc. Pyridinyl and pyrimidinyl sulfonamide derivatives as chemokine receptor modulators

Also Published As

Publication number Publication date
US9550746B2 (en) 2017-01-24
US20150218119A1 (en) 2015-08-06
US8815915B2 (en) 2014-08-26
AU2018200226A1 (en) 2018-01-25
US20130231339A1 (en) 2013-09-05
AU2018200226B2 (en) 2019-09-19
US20130231338A1 (en) 2013-09-05
PL2820010T3 (pl) 2018-11-30
EP3345899B1 (en) 2020-02-19
EP3345899A1 (en) 2018-07-11
AU2013225815A1 (en) 2014-09-25
ES2791534T3 (es) 2020-11-04
PL3345899T3 (pl) 2020-07-27
ES2683046T3 (es) 2018-09-24
EP2820010A1 (en) 2015-01-07
CA2866078A1 (en) 2013-09-06
US8927544B2 (en) 2015-01-06
CA2866078C (en) 2018-01-02
CY1120528T1 (el) 2019-07-10
DK3345899T3 (da) 2020-05-11
US20140329813A1 (en) 2014-11-06
AU2013225815B2 (en) 2017-10-12
PT3345899T (pt) 2020-05-20
HUE038700T2 (hu) 2018-11-28
WO2013130962A1 (en) 2013-09-06
WO2013130958A1 (en) 2013-09-06
DK2820010T3 (en) 2018-08-06
SI2820010T1 (sl) 2018-11-30
HUE049728T2 (hu) 2020-10-28
US9416120B2 (en) 2016-08-16
EP2820010B1 (en) 2018-05-09

Similar Documents

Publication Publication Date Title
HK1232219A1 (zh) 作為趨化因子受體調節劑的硫衍生物
IL237212A0 (en) Amide derivatives of benzoimidazole carboxylic acid as apj receptor modulators
GB201213700D0 (en) Receptor antagnists II
IL251897A0 (en) X-receptor modulators of the liver
HK1206333A1 (en) Liver receptor modulators
HK1208867A1 (en) Indolecarbonitriles as selective androgen receptor modulators
HK1209744A1 (en) Novel selective androgen receptor modulators
HK1211025A1 (en) Indolines
IL235557A0 (en) Modulators of 17 gpr receptors
GB201217285D0 (en) Indole derivatives
PT3345899T (pt) Derivados de benzofurano-2-sulfonamida como moduladores dos receptores de quimioquinas
GB201223053D0 (en) Receptor
AU2012904244A0 (en) Neurotrophin-tyrosine kinase receptor signaling